相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preventing murine transfusion-related acute lung injury by expansion of CD4+CD25+FoxP3+ Tregs using IL-2/anti-IL-2 complexes
Rui He et al.
TRANSFUSION (2019)
Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives
Ken-ichi Matsuoka
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
Systemic IL-2/anti-IL-2Ab complex combined with sublingual immunotherapy suppresses experimental food allergy in mice through induction of mucosal regulatory T cells
P. L. Smaldini et al.
ALLERGY (2018)
Interleukin 2 Promotes Hepatic Regulatory T Cell Responses and Protects From Biliary Fibrosis in Murine Sclerosing Cholangitis
Amy E. Taylor et al.
HEPATOLOGY (2018)
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
Eleonora Trotta et al.
NATURE MEDICINE (2018)
Low-dose IL-2 expands CD4+ regulatory T cells with a suppressive function in vitro via the STAT5-dependent pathway in patients with chronic kidney diseases
Yuanyuan Li et al.
RENAL FAILURE (2018)
Treatment of T1D via optimized expansion of antigen- specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramers
Cristina Izquierdo et al.
SCIENTIFIC REPORTS (2018)
IL-2-Anti-IL-2 Monoclonal Antibody Immune Complexes Inhibit Collagen-Induced Arthritis by Augmenting Regulatory T Cell Functions
Yuichi Yokoyama et al.
JOURNAL OF IMMUNOLOGY (2018)
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
Laurence B. Peterson et al.
JOURNAL OF AUTOIMMUNITY (2018)
In Vivo Expansion of Regulatory T Cells with IL-2/IL-2 Antibody Complex Protects against Transient Ischemic Stroke
Haiyue Zhang et al.
JOURNAL OF NEUROSCIENCE (2018)
Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial
Tian Xiao Zhao et al.
BMJ OPEN (2018)
IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
Brian C. Betts et al.
HAEMATOLOGICA (2017)
IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4+CD25+Foxp3+ regulatory T cells
Ji-Jing Yan et al.
KIDNEY INTERNATIONAL (2017)
IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors
Gavin Whitehouse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
Brian C. Betts et al.
HAEMATOLOGICA (2017)
The IL-2/Anti-IL-2 Complex Attenuates Cardiac Ischaemia-Reperfusion Injury Through Expansion of Regulatory T Cells
Junhui Xiao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Caroline von Spee-Mayer et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2
Connor J. Dwyer et al.
CURRENT DIABETES REPORTS (2016)
Restoring regulation - IL-2 therapy in systemic lupus erythematosus
Jens Y. Humrich et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Jing He et al.
NATURE MEDICINE (2016)
In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation
Maryam Tahvildari et al.
TRANSPLANTATION (2016)
Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study
Xiang-Yu Zhao et al.
ONCOIMMUNOLOGY (2016)
Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
Jens Y. Humrich et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
Michelle Rosenzwajg et al.
JOURNAL OF AUTOIMMUNITY (2015)
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
David Klatzmann et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Administration of Low Doses of IL-2 Combined to Rapamycin Promotes Allogeneic Skin Graft Survival in Mice
C. B. Pilon et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
Emeline Castela et al.
JAMA DERMATOLOGY (2014)
The life of regulatory T cells
Iris K. Gratz et al.
TRANSLATIONAL IMMUNOLOGY IN ASIA-OCEANIA (2013)
IL-2/Anti-IL-2 Complex Attenuates Renal Ischemia-Reperfusion Injury through Expansion of Regulatory T Cells
Myung-Gyu Kim et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
Ken-ichi Matsuoka et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Effect of Rapamycin and Interleukin-2 on Regulatory CD4+CD25+Foxp3+ T Cells in Mice After Allogenic Corneal Transplantation
X. Wang et al.
TRANSPLANTATION PROCEEDINGS (2013)
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
Agnes Hartemann et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
CTLA4-Ig Restores Rejection of MHC Class-II Mismatched Allografts by Disabling IL-2-Expanded Regulatory T Cells
L. -M. Charbonnier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes
Michelle Rosenzwajg et al.
CURRENT DIABETES REPORTS (2012)
Impact of Interleukin-2-expanded Regulatory T Cells in Various Allogeneic Combinations on Mouse Skin Graft Survival
B. Vokaer et al.
TRANSPLANTATION PROCEEDINGS (2012)
CD4+Foxp3+ regulatory T cell therapy in transplantation
Qizhi Tang et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2012)
The role of interleukin-2 during homeostasis and activation of the immune system
Onur Boyman et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
David Saadoun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Regulatory T Cells: Customizing for the Clinic
Xuehao Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
NFAT pulls the strings during CD4+ T helper cell effector functions
Natascha Hermann-Kleiter et al.
BLOOD (2010)
In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression
Kylie E. Webster et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Genetics of Type 1A Diabetes
Patrick Concannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Suppression of Murine Allergic Airway Disease by IL-2:Anti-IL-2 Monoclonal Antibody-Induced Regulatory T Cells
Mark S. Wilson et al.
JOURNAL OF IMMUNOLOGY (2008)
Selective stimulation of T cell subsets with antibody-cytokine immune complexes
O Boyman et al.
SCIENCE (2006)
Costimulation blockade with belatacept in renal transplantation
F Vincenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth
BM Rao et al.
BIOCHEMISTRY (2005)
Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
R Setoguchi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Type 1 diabetes genes and pathways shared by humans and NOD mice
LS Wicker et al.
JOURNAL OF AUTOIMMUNITY (2005)
Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis
E Gambineri et al.
CURRENT OPINION IN RHEUMATOLOGY (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse
ME Brunkow et al.
NATURE GENETICS (2001)
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
CL Bennett et al.
NATURE GENETICS (2001)
分享论文
